ID: ALA3273607

Max Phase: Preclinical

Molecular Formula: C43H65N11O12S2

Molecular Weight: 992.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O

Standard InChI:  InChI=1S/C43H65N11O12S2/c1-5-23(4)36-42(65)49-26(12-13-32(44)56)38(61)51-30(19-33(45)57)39(62)50-27(14-16-67-68-21-35(59)48-29(40(63)53-36)18-24-8-10-25(55)11-9-24)43(66)54-15-6-7-31(54)41(64)52-28(17-22(2)3)37(60)47-20-34(46)58/h8-11,22-23,26-31,36,55H,5-7,12-21H2,1-4H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,47,60)(H,48,59)(H,49,65)(H,50,62)(H,51,61)(H,52,64)(H,53,63)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1

Standard InChI Key:  XCMPPQBNOVBSLA-QPLNMOKZSA-N

Associated Targets(non-human)

Oxytocin receptor 839 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 992.19Molecular Weight (Monoisotopic): 991.4256AlogP: -2.55#Rotatable Bonds: 17
Polar Surface Area: 373.51Molecular Species: NEUTRALHBA: 14HBD: 11
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.50CX Basic pKa: CX LogP: -3.81CX LogD: -3.81
Aromatic Rings: 1Heavy Atoms: 68QED Weighted: 0.07Np Likeness Score: 0.47

References

1. Smith CW, Ferger MF..  (1976)  Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.,  19  (2): [PMID:1249804] [10.1021/jm00224a010]

Source